当前位置: 首页 > 详情页

LncAPC drives Wnt/β-catenin activation and liver TIC self-renewal through EZH2 mediated APC transcriptional inhibition

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Histology and Embryology, College of Basic Medicine, Zhengzhou University, Henan, China [2]Department of Cancer Biology Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou University, Henan, China [3]Department of Otolaryngology, Medical School, University of Minnesota, Twin Cities Campus, Minneapolis, Minnesota [4]Department of Pathology, School of Medicine, University of Virginia, Virginia [5]Department of Nuclear Medicine, The Affiliated Beijing Anzhen Hospital of Capital Medical University, Capital Medical University, Beijing, China [6]Department of Hepatopancreatobiliary Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou University, Henan, China
出处:
ISSN:

关键词: liver cancer long noncoding RNA remodeling complex tumor initiating cells Wnt/β-catenin

摘要:
Liver tumor initiating cells (TICs), a small subset cells in tumor bulk, are responsible for liver tumor initiation, metastasis, and relapse. However, the regulatory mechanism of liver TICs remains largely unknown. Here we found a long noncoding RNA lncAPC, locating near from APC locus, was highly expressed in liver cancer and liver TICs. LncAPC was required for liver TIC self-renewal. Silencing and overexpressing lncAPC showed impaired and enhanced sphere formation capacity of liver TICs, respectively. By recruiting EZH2 to APC promoter, LncAPC inhibits APC transcription and thus drives the activation of Wnt/β-catenin signaling. Attenuate binding between EZH2 and APC promoter was observed upon lncAPC knockdown. What is more, lncAPC-EZH2-APC axis can be targeted to eliminate liver TICs. Altogether, LncAPC promotes liver TIC self-renewal through EZH2-dependent APC transcriptional inhibition. © 2017 Wiley Periodicals, Inc.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2017]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 2 区 肿瘤学
最新[2023]版:
大类 | 2 区 医学
小类 | 2 区 生化与分子生物学 3 区 肿瘤学
JCR分区:
出版当年[2016]版:
Q1 BIOCHEMISTRY & MOLECULAR BIOLOGY Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2016版] 出版当年五年平均 出版前一年[2015版] 出版后一年[2017版]

第一作者:
第一作者机构: [1]Department of Histology and Embryology, College of Basic Medicine, Zhengzhou University, Henan, China [2]Department of Cancer Biology Immunotherapy, The Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou University, Henan, China
通讯作者:
通讯机构: [1]Department of Histology and Embryology, College of Basic Medicine, Zhengzhou University, Henan, China [*1]Department of Histology and Embryology, College of Basic Medicine, Zhengzhou University, 100 Kexue Road, Zhengzhou, Henan 450052, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院